Mustafa Vayvada, Ayse Nigar Halis, Pinar Atagun Guney, Sevinc Citak, Ali Yiginsu, Atakan Erkilic, Ahmet Erdal Tasci

Patients with idiopathic pulmonary fibrosis referred forlung transplantation: Initial institutional experience in Turkey

Aim: Lung transplantation is the only therapeutic option that can improve survival and quality of life for idiopathic pulmonary fibrosis(IPF) despite recent advances in medical treatment. This study aimed to analyze mortality during the waiting list in IPF patients listed for lung transplantation since the implementation of the lung transplant program.Materials and Methods: Patients with IPF listed for lung transplantation were retrospectively analyzed between December 2016 andDecember 2018. Moreover, patients were excluded if they have been referred for lung transplantation and were not suitable after evaluation.Results: A total of 28 patients with IPF were listed for lung transplantation. The waiting list mortality rate was 39.3% (11/28). Themedian days on the waiting list were 71.2 days (range, 3–206) in patients who underwent lung transplantation and 110 days (range, 14–303) in patients who died on the waiting list. No differences in the demographic and clinical data were observed between both groups. Arterial blood gas saturation was statistically significantly lower in patients who died on the waiting list (74.2% vs. 82.9%, p = 0.046). Two single and 15 bilateral lung transplants were performed. Hospital mortality rate was 23.5% (4/17). The 1- and 3-year survival rates were 70.6%.Conclusion: Lung transplantation is the only treatment option for patients with IPF who are not responsive to medicinal treatment.The late referral may lead to mortality on the waiting list. Thus, patients newly diagnosed with IPF should be promptly referred to a transplant center for evaluation.

PDF

___

1. Raghu G, Remy-Jardin M, Myers JL, et al. American Thoracic Society, European Respiratory Society,
Japanese Respiratory Society, and Latin American
Thoracic Society. Diagnosis of Idiopathic Pulmonary
Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical
Practice Guideline. Am J Respir Crit Care Med 2018;
198:44-68.
2. Guenther A, Krauss E, Tello S, et al. The European
IPF registry (eurIPFreg): baseline characteristics and
survival of patients with idiopathic pulmonary fibrosis.
Respir Res 2018;19:141.
3. Weill D, Benden C, Corris PA, et al. A consensus
document for the selection of lung transplant
candidates: 2014--an update from the Pulmonary
Transplantation Council of the International Society
for Heart and Lung Transplantation. J Heart Lung
Transplant 2015;34:1-15.
4. Kistler KD, Nalysnyk L, Rotella P, et al. Lung
transplantation in idiopathic pulmonary fibrosis: a
systematic review of the literature. BMC Pulm Med
2014;16:139.
5. Dotan Y, Vaidy A, Shapiro WB, et al. Effect of Acute
Exacerbation of Idiopathic Pulmonary Fibrosis on
Lung Transplantation Outcome. Chest 2018;154:818-
26.
6. Kim ES, Choi SM, Lee J, et al. Validation of the GAP
score in Korean patients with idiopathic pulmonary
fibrosis. Chest 2015;147:430-7.
7. Chambers, DC, Yusen RD, Cherikh WS, et al. The
Registry of the International Society for Heart and Lung
Transplantation: Thirty-fourth Adult Lung and Heart-
Lung Transplantation Report-2017; Focus Theme:
Allograft ischemic time. J. Heart Lung Transplant
2017;36: 1047-59.
8. Lettieri CJ, Nathan SD, Barnett SD, et al. Prevalence
and outcomes of pulmonary arterial hypertension
in advanced idiopathic pulmonary fibrosis. Chest
2006;129:746-52.
9. Nathan SD, Shlobin OA, Ahmad S, et al. Serial
development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration
2008;76:288-94.
10. Han MK, Bach DS, Hagan PG, et al. IPFnet Investigators.
Sildenafil preserves exercise capacity in patients
with idiopathic pulmonary fibrosis and right-sided
ventricular dysfunction. Chest 2013;143:1699-708.
11. Saggar R, Khanna D, Vaidya A, et al. Changes in
right heart haemodynamics and echocardiographic
function in an advanced phenotype of pulmonary
hypertension and right heart dysfunction associated
with pulmonary fibrosis. Thorax. 2014;69:123-9.
12. Valapour M, Lehr CJ, Skeans MA, et al. OPTN/SRTR
2017 Annual Data Report: Lung. Am J Transplant
2019;19:404-84.
13. Mackay LS, Anderson RL, Parry G, et al.
Pulmonaryfibrosis: rate of disease progression as
a trigger for referral for lung transplantation. Thorax
2007;62:1069-73.
14. Chen H, Shiboski SC, Golden JA, et al. Impact of the
lung allocation score on lung transplantation for
pulmonary arterial hypertension. Am J Respir Crit
Care Med 2009;180:468-74.
15. Chambers DC, Cherikh WS, Harhay MO, et
al. International Society for Heart and Lung
Transplantation. The International Thoracic Organ
Transplant Registry of the International Society for
Heart and Lung Transplantation: Thirty-sixth adult
lung and heart-lung transplantation Report-2019;
Focus theme: Donor and recipient size match. J Heart
Lung Transplant 2019;38:1042-55.
16. Brown AW, Kaya H, Nathan SD. Lung transplantation in
IIP: A review. Respirology 2016;21:1173-84.
17. Andrade J, Schwarz M, Collard HR, et al. IPFnet
Investigators. The Idiopathic Pulmonary Fibrosis
Clinical Research Network (IPFnet): diagnostic and
adjudication processes. Chest 2015;148:1034-42.
18. Ley B, Bradford WZ, Vittinghoff E, et al. Predictors
of Mortality Poorly Predict Common Measures of
Disease Progression in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med 2016;194:711-8.
19. George PM, Patterson CM, Reed AK, et al. Lung
transplantation for idiopathic pulmonary fibrosis.
Lancet Respir Med 2019;7:271-82.
20. Delanote I, Wuyts WA, Yserbyt J, et al. Safety and
efficacy of bridging to lung transplantation with
antifibrotic drugs in idiopathic pulmonary fibrosis: a case series. BMC Pulm Med 2016;16:156.
21. Leuschner G, Stocker F, Veit T, et al. Outcome of lung
transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy. J Heart Lung Transplant
2018;37:268-74.
22. Villavicencio MA, Axtell AL, Osho A, et al. Single-
Versus Double-Lung Transplantation in Pulmonary
Fibrosis: Impact of Age and Pulmonary Hypertension.
Ann Thorac Surg 2018;106:856-63.
23. Nasir BS, Mulvihill MS, Barac YD, , et al. Single lung
transplantation in patients with severe secondary
pulmonary hypertension. J Heart Lung Transplant
2019;38:939-48.